BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20180311T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20181104T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20180311T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20181104T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190909
DTEND;VALUE=DATE:20190910
DTSTAMP:20190812T140040Z
CREATED:20190812T140040Z
LAST-MODIFIED:20190812T140040Z
UID:29961-1567987200-1568073599@globalbiodefense.com
SUMMARY:Comments Due:  2019 Draft Guidelines for the Prevention\, Diagnosis\, and Treatment of Lyme Disease
DESCRIPTION:The Infectious Diseases Society of America (IDSA)\, American Academy of Neurology (AAN)\, and American College of Rheumatology (ACR) are now accepting comments on the “2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease.” Feedback is sought not only from physicians and healthcare professionals\, but also individuals affected by Lyme disease\, such as patients\, care givers\, patient organization members\, advocates\, and researchers. The deadline for submitting comments has been extended until Sept. 9\, 2019. \nTo view the draft guidelines\, supplementary materials\, and submit comments\, please see below. \n2019 Draft Guidelines for the Prevention\, Diagnosis and Treatment of Lyme Disease \n2019 Draft Supplement Materials for the Prevention\, Diagnosis and Treatment of Lyme Disease \nPublic comments are due by 5PM Eastern on 9 September 2019.
URL:https://globalbiodefense.com/event/comments-due-2019-draft-guidelines-for-the-prevention-diagnosis-and-treatment-of-lyme-disease/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190719
DTEND;VALUE=DATE:20190720
DTSTAMP:20190421T174235Z
CREATED:20190421T172854Z
LAST-MODIFIED:20190421T174235Z
UID:26391-1563494400-1563580799@globalbiodefense.com
SUMMARY:Proposals Due: RNCP-Wide Dosimetry Guidance and Monitoring of Sources and Irradiation Protocols
DESCRIPTION:NIAID is soliciting proposals to assess the current state of radiation dosimetry within the Radiation Nuclear Countermeasures Program to develop a consistent means of comparison and reproducibility across institutes. \nConsider submitting an offer if you can provide services\, facilities\, expertise\, and capabilities needed to develop a centralized dosimetry harmonization effort. Ideally\, you will have preliminary data demonstrating consistent and accurate dosimetry exposures within a clearly defined radiation exposure system that is used for nonclinical radiation animal (and in vitro) studies in more than one animal species (e.g.\, mouse and nonhuman primate). \nRead the full article on this opportunity here.  \nResponses are due July 19\, 2019\, at 3 p.m. Eastern time.
URL:https://globalbiodefense.com/event/proposals-due-rncp-wide-dosimetry-guidance-and-monitoring-of-sources-and-irradiation-protocols/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190630
DTEND;VALUE=DATE:20190701
DTSTAMP:20190619T043333Z
CREATED:20190602T043051Z
LAST-MODIFIED:20190619T043333Z
UID:29329-1561852800-1561939199@globalbiodefense.com
SUMMARY:Estimated Release Date of Draft WHO Roadmap on Neglected Tropical Diseases 2012–2020
DESCRIPTION:At its eleventh meeting in 2018\, the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD) recommended that WHO initiate a consultative process with the global NTD community to set new targets and milestones beyond 2020 to achieve the health-related 2030 United Nations Sustainable Development Goals (SDGs). \nPhase 1 feedback was collected\, summarized and presented on 29-30 April 2019 at a STAG-NTD meeting. A second round of feedback from stakeholders will take place following the late June release of the Roadmap draft with the goal of finalizing the Roadmap and milestones by 1 August. \nSource: World Health Organization
URL:https://globalbiodefense.com/event/estimated-release-date-of-draft-who-roadmap-on-neglected-tropical-diseases-2012-2020/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190626
DTEND;VALUE=DATE:20190627
DTSTAMP:20190620T150001Z
CREATED:20190620T150001Z
LAST-MODIFIED:20190620T150001Z
UID:29344-1561507200-1561593599@globalbiodefense.com
SUMMARY:GHSA Supplemental Funding Opportunity Application Deadline - Ebola\, Cholera Outbreak Response
DESCRIPTION:CDC’s Emergency Response and Recovery Branch may have funds available to support emergency activities in response to the Ebola outbreak in the Democratic Republic of the Congo\, the Rohingya refugee crisis in Bangladesh\, and/or global cholera outbreak response. \nIn response to the recent Ebola outbreak in West Africa\, Emergency Response and Recovery Branch (ERRB) has coordinated the establishment of CDC’s Global Rapid Response Team (GRRT). This funding opportunity supports the implementation of programs and activities targeted at increasing the rapid response capacity of CDC’s partners to support populations affected by disease outbreaks\, complex humanitarian emergencies\, armed conflict and other disasters. Its purpose is to decrease the time needed to respond to critical public health emergencies through the provision of logistical mechanisms required for the rapid public health response to humanitarian emergencies and disease outbreaks throughout the world. This effort will expand CDC’s ability to respond quickly and effectively in the event of public health emergencies worldwide. \nAfter a partner organization is initially selected for funding for a specific strategy and activity\, that partner organization may be requested to provide an application for additional strategies and activities through supplemental funding requests and/or a continuation application at the time when CDC solicits the partner organizations for a request for application for emergency funding. Requests to expand strategies and activities are not limited to particular focus areas or countries where the organization was initially selected for funding. It remains at the partner organizations’ discretion to submit an application in response to these supplemental requests or request for applications. \nRead more: Emergency Response and Recovery Supplemental Funding for GHSA Support
URL:https://globalbiodefense.com/event/ghsa-supplemental-funding-opportunity-application-deadline-ebola-cholera-outbreak-response/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190620
DTEND;VALUE=DATE:20190621
DTSTAMP:20190617T153157Z
CREATED:20190617T153157Z
LAST-MODIFIED:20190617T153157Z
UID:29307-1560988800-1561075199@globalbiodefense.com
SUMMARY:CDC RFI Deadline: Rapid Response to Outbreaks for Sample Collection
DESCRIPTION:CDC is seeking information from companies and other organizations about their capability and capacity to deploy to the site of a domestic or international outbreak or public health emergency\, obtain informed consent\, collect specimens (blood\, urine\, swabs\, etc.) from identified patients\, and safely ship these specimens to CDC in accordance with all applicable local\, state\, and federal and/or international laws\, and regulations. \nAdditionally\, the agency is seeking to obtain information\, needs\, capabilities\, constraints\, capacities\, and requirements of those vendors and companies who do have an interest (or potential interest) in providing the needed services. \nRead more: Collection of Specimens During Outbreak or Public Health Emergency
URL:https://globalbiodefense.com/event/cdc-rfi-deadline-rapid-response-to-outbreaks-for-sample-collection/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190520
DTEND;VALUE=DATE:20190521
DTSTAMP:20190421T201832Z
CREATED:20190421T201149Z
LAST-MODIFIED:20190421T201832Z
UID:26412-1558310400-1558396799@globalbiodefense.com
SUMMARY:RFI Deadline - Malaria Prophylactic Drug Tafenoquine
DESCRIPTION:The U.S. Army Medical Research Acquisition Activity (USAMRAA) located at FT. Detrick\, MD\, has issued a solicitation outlining plans to conduct User Acceptance Testing for the malaria prophylactic drug (Tafenoquine) brand name Arakoda. \nThe operational testing will look at the drug’s performance attributes and usability. \nThe DoD is seeking sources\, capability statements\, and industry feedback for this requirement for one commercial lot of ~120\,000 tablets (7\,500 packages) of Tafenoquine brand name Arakoda immediately\, with base Contract Line Item Number (CLIN) and three optional CLINs to procure up to 3\,750 packages per CLIN. \nEntities interested in submitting a response must furnish in writing\, a 2-3 page (not including cover page\, index or list of references) synopsis of their capability to provide the described product\, including any necessary lead time. \nResponses are due Monday\, 20 May 2019\, 3:00 PM EST. \nRead the full article on the Malaria Drug RFI here.
URL:https://globalbiodefense.com/event/rfi-deadline-malaria-prophylactic-drug-tafenoquine/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/global-biodefense-events-calendar-7.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190503
DTEND;VALUE=DATE:20190504
DTSTAMP:20190429T042725Z
CREATED:20190402T041450Z
LAST-MODIFIED:20190429T042725Z
UID:27085-1556841600-1556927999@globalbiodefense.com
SUMMARY:Eureka Prize for Infectious Diseases Research
DESCRIPTION:Entries are being accepted for the Eureka Prize for Infectious Diseases Research through 3 May 2019. \nActivity entered for this prize must have been undertaken in Australia or its territories (as defined by the Australian Government). \nFor a team entry\, the team leader must be either a) an Australian citizen\, b) an Australian permanent resident\, or c) a New Zealand citizen who was resident in Australia\, at the time the research entered was undertaken. \nSponsored by the Australian Infectious Diseases Research Centre\, the $10\,000 prize is awarded to an individual\, group or team for an outstanding recent contribution to infectious diseases research. \nActivity entered for this prize must have been undertaken as a single body of focused infectious diseases research in the past 7 years and have been published in one or more internationally respected scientific journals\, books or equivalent electronic publications. \nPlease visit the Eureka Prize for Infectious Diseases Research website for more information.
URL:https://globalbiodefense.com/event/eureka-prize-for-infectious-diseases-research/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2019/04/biodefense-health-security-opportunity-deadline.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190308
DTEND;VALUE=DATE:20190309
DTSTAMP:20240623T192421Z
CREATED:20190224T232313Z
LAST-MODIFIED:20240623T192421Z
UID:24699-1552003200-1552089599@globalbiodefense.com
SUMMARY:Call for Reports: Evidence-Based Practices for Public Health Emergency Preparedness and Response
DESCRIPTION:Committee on Evidence – Based Practices for Public Health Emergency Preparedness and Response \nThe National Academies of Sciences\, Engineering\, and Medicine s soliciting information to help inform the deliberations of a consensus study committee sponsored by the Centers for Disease Control and Prevention. \nThe committee has been charged with conducting a comprehensive review and grading of the evidence for select public health emergency preparedness and response (PHEPR) practices. The committee’s report will provide recommendations on PHEPR practices that public health agencies should or should not adopt based on the evidence and will also identify future research needs to address gaps in evidence-based PHEPR practices. \nThe committee is issuing a call for reports to help enhance its comprehensive review. \nAnyone wishing to submit reports should email the committee at preparedness@nas.edu. Materials should be submitted by Friday\, March 8\, 2019. Please note that any materials or written information shared with the committee will be placed in the committee’s Public Access File (PAF)\, and may be provided to the public upon request.
URL:https://globalbiodefense.com/event/call-for-reports-evidence-based-practices-for-public-health-emergency-preparedness-and-response/
CATEGORIES:Deadlines
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190308
DTEND;VALUE=DATE:20190309
DTSTAMP:20240623T231311Z
CREATED:20190223T200908Z
LAST-MODIFIED:20240623T231311Z
UID:23755-1552003200-1552089599@globalbiodefense.com
SUMMARY:Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance
DESCRIPTION:Submit Feedback on NIAID’s Research Framework for Antibacterial Resistance by March 8\, 2019. \nNIAID is refining the five-year strategic framework for antibacterial resistance (AR) research and development\, Antibacterial Resistance Program: Current Status and Future Directions pdf. \nPublished in 2014\, the framework identified the following priorities: \n\nSystems Biology and Antibacterial Resistance: New Directions for Drug Discovery\nHarnessing the Immune System to Combat Bacterial Infections\nDisarm\, But Leave Unharmed: Exploring Anti-Virulence Strategies\nSynthetic Microbiota: An Ecobiological Approach\nLess Is Better: Diagnostics to Guide Use of Narrow-Spectrum Therapeutics\nExploiting Natural Predators: The Specificity of Phage Therapy\nTeaching Old Drugs New Tricks: Extending the Clinical Utility of Antibacterial Drugs\n\nNIAID seeks community feedback to inform an update of the framework. Send your comments identifying: \n\nAdditional research activities needed to help advance the above-listed strategic approaches\nAdditional strategic approaches or technologies that have the potential to transform our understanding of and ability to prevent\, diagnose\, or treat resistant bacterial infections\n\nTo submit a response\, send a PDF or MS Word document of 500 words or less to NIAIDAntibioticResistanceRFI2019@niaid.nih.gov. The deadline to reply is March 8\, 2019. Take care to avoid sharing any proprietary\, classified\, confidential\, trade secret\, or sensitive information in your response.
URL:https://globalbiodefense.com/event/niaid-research-framework-amr-deadline-2019/
CATEGORIES:Deadlines
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190128
DTEND;VALUE=DATE:20190129
DTSTAMP:20190125T013842Z
CREATED:20190125T013614Z
LAST-MODIFIED:20190125T013842Z
UID:22171-1548633600-1548719999@globalbiodefense.com
SUMMARY:Comments Due: Code of Conduct for Timely Sharing of Pathogen Genetic Sequence Data During Outbreak
DESCRIPTION:A key concern in recent outbreaks has been variable timelines between the start of an outbreak and the public availability of the first and subsequent genetic sequences. \nThe World Health Organization (WHO)\, upon consultation with many stakeholders and institutions working in the pathogen sequencing arena\, is proposing elements of a code of conduct for genetic sequencing data sharing in infectious disease outbreaks. \nThrough this code of conduct WHO seeks to enable rapid international sharing of sequence data\, allowing public health authorities\, product developers and researchers to collaborate more effectively from a position of mutual trust with respect for submitters’ rights to the information they provide. \nThe draft document is available for public comment until close of business on 28 January 2019. Comments may be submitted by individuals or organizations\, and will be considered for incorporation in WHO’s final Code of Conduct.
URL:https://globalbiodefense.com/event/comments-due-code-of-conduct-for-timely-sharing-of-pathogen-genetic-sequence-data-during-outbreak/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
ATTACH;FMTTYPE=image/png:https://globalbiodefense.com/wp-content/uploads/2019/01/genomic-sequencing-data-sharing-code-of-conduct.png
END:VEVENT
END:VCALENDAR